Home

Cingulate Inc. - Common Stock (CING)

4.5500
0.00 (0.00%)

Cingulate Inc is a biopharmaceutical company focused on developing innovative treatments for patients with attention-related disorders, particularly attention deficit hyperactivity disorder (ADHD)

The company's expertise lies in creating unique formulations that aim to improve medication adherence and enhance therapeutic outcomes for individuals affected by these conditions. Through advanced drug delivery systems and proprietary technologies, Cingulate is committed to addressing unmet medical needs and providing healthcare professionals with effective therapeutic options tailored to the complexities of ADHD.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Cingulate Inc. - Common Stock publicly traded?
Yes, Cingulate Inc. - Common Stock is publicly traded.
What exchange does Cingulate Inc. - Common Stock trade on?
Cingulate Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cingulate Inc. - Common Stock?
The ticker symbol for Cingulate Inc. - Common Stock is CING on the Nasdaq Stock Market
What is the current price of Cingulate Inc. - Common Stock?
The current price of Cingulate Inc. - Common Stock is 4.550
When was Cingulate Inc. - Common Stock last traded?
The last trade of Cingulate Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025